Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations and Business Activities (Details)

v3.23.2
Nature of Operations and Business Activities (Details)
 3 Months Ended 6 Months Ended
Jul. 24, 2023
USD ($)
Feb. 16, 2023
USD ($)
$ / shares
shares
Nov. 10, 2022
USD ($)
Jun. 30, 2023
USD ($)
$ / shares
Mar. 31, 2023
USD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Jun. 30, 2023
USD ($)
$ / shares
Jun. 30, 2022
USD ($)
Jan. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Nature Of Operations And Business Activities [Line Items]                      
Working capital deficit       $ 7,923,867       $ 7,923,867      
Accumulated deficit       75,016,785       75,016,785     $ 66,737,765
Cash and cash equivalents       553,443   $ 2,929,895   553,443 $ 2,929,895    
Operating loss       2,842,997   3,218,360   5,943,155 6,106,382    
Net loss       3,111,500 $ 5,167,520 $ 3,419,278 $ 3,043,399 8,279,020 $ 6,462,677    
Estimate for legal contingency       6,235,639       6,235,639   $ 6,205,310 $ 6,205,310
Coverage received to cover legal expenses       $ 5,000,000       $ 5,000,000      
Exercise price (in dollars per share) | $ / shares       $ 0.10       $ 0.10      
Number of EHT warrants outstanding (in shares) | shares   0                  
Subsequent Event | Bridge Loan                      
Nature Of Operations And Business Activities [Line Items]                      
Debt, face amount $ 250,000                    
Interest rate (as a percent) 9.50%                    
Debt Instrument, payable, term 30 days                    
MTA Warrants, Credit Consideration                      
Nature Of Operations And Business Activities [Line Items]                      
Common stock issuance costs   $ 1,597,236           $ 1,597,236      
Common Stock Warrants | MTA Warrants                      
Nature Of Operations And Business Activities [Line Items]                      
Exercise price (in dollars per share) | $ / shares   $ 282,905   $ 282,905       $ 282,905      
Discontinued Operations, Disposed of by Sale | Verdelite SPA                      
Nature Of Operations And Business Activities [Line Items]                      
Aggregate purchase price     $ 9,451,233                
Proceeds from asset sale, net of legal expenses     $ 5,532,266                
Emerald Health Therapeutics, Inc.                      
Nature Of Operations And Business Activities [Line Items]                      
Exchange ratio     1.95